The global Acute Lung Injury (ALI) market is poised for steady expansion over the next several years. In 2023 the market was valued at about USD 1,272.7 million, and projections indicate it will grow to USD 1,308.6 million in 2024 and reach roughly USD 1,634.9 million by 2031. This growth trajectory corresponds to a compound annual growth rate (CAGR) of approximately 3.23%...
The analgesics market has experienced significant evolution in recent years, driven by growing global healthcare demands, rising prevalence of chronic pain, and increased focus on patient-centric therapies. Analgesics, commonly referred to as pain-relieving medications, include nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, and acetaminophen-based drugs. Their widespread adoption...